Orchestra BioMed Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Orchestra BioMed Holdings, Inc. (OBIO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $14.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $14.40M, a 57.40% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $33.80M, a 146.72% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $13.70M, a 55.68% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $8.80M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $14.40M 10-K · filed 2026-03-12 |
| 2024-12-31 | $33.80M 10-K · filed 2026-03-12 |
| 2023-12-31 | $13.70M 10-K · filed 2025-03-31 |
| 2022-12-31 | $8.80M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |